PHF23 (PHD Finger Protein 23) is a nuclear chromatin-binding protein that functions as an epigenetic "reader" by recognizing specific histone modifications through its Plant Homeodomain (PHD) zinc finger. The PHF23 gene (ENSG00000116161) is located on chromosome 17p13.1 and encodes a protein of 445 amino acids. This small protein plays crucial roles in gene regulation, developmental biology, and increasingly recognized functions in neuronal biology and neurodegeneration 1.
Epigenetic regulation—heritable changes in gene expression without alterations to the DNA sequence—has emerged as a critical area of investigation in neurodegenerative diseases. Histone modifications, DNA methylation, and chromatin remodeling all contribute to the precise temporal and spatial control of gene expression necessary for neuronal survival and function. PHF23, as a histone reader protein, bridges the recognition of specific histone marks to the recruitment of effector complexes that modulate chromatin state and gene transcription 2.
Dysregulation of epigenetic machinery has been documented in multiple neurodegenerative conditions, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and Amyotrophic Lateral Sclerosis (ALS). PHF23 and related PHD finger proteins represent potential therapeutic targets for modulating these epigenetic changes and potentially slowing or reversing neurodegeneration.
The PHF23 gene spans approximately 4.5 kb of genomic DNA and comprises 6 exons. It encodes a protein of 445 amino acids with a molecular weight of approximately 48 kDa. The gene is located on chromosome 17p13.1, a region frequently altered in various neurological conditions.
PHF23 contains several functional domains:
PHD Finger Domain (C-terminal)
N-terminal Region
Nuclear Localization Signal (NLS)
The PHD finger of PHF23 adopts a distinct structural fold:
Structural studies reveal:
The primary function of PHF23 is to serve as an epigenetic reader—a protein that recognizes specific histone modifications and translates them into downstream biological effects. This process involves:
PHF23 exhibits specificity for:
PHF23 interacts with multiple chromatin-associated complexes:
| Complex | Interaction | Function |
|---|---|---|
| HDAC complexes | Recruitment | Histone deacetylation |
| HMT complexes | Recruitment | Histone methylation |
| SWI/SNF | Chromatin remodeling | Gene activation |
| LSD1/CoREST | Histone demethylation | Repression |
PHF23 modulates gene expression through:
In neurons, PHF23 regulates:
PHF23 is implicated in AD pathogenesis through multiple mechanisms 3:
Histone modification changes:
Transcriptional dysfunction:
Therapeutic implications:
PHF23 contributes to PD through:
Dopaminergic neuron vulnerability:
α-Synuclein toxicity:
PHF23 and related proteins:
Epigenetic changes in ALS:
PHF23 altered in various cancers:
| Tissue | Expression Level | Primary Role |
|---|---|---|
| Brain | Very High | Epigenetic regulation |
| Testis | High | Spermatogenesis |
| Ovary | Moderate | Oogenesis |
| Heart | Low | Basal expression |
| Lung | Low | Basal expression |
| Liver | Low | Basal expression |
Within the brain, PHF23 is expressed in:
PHF23 localizes:
Targeting PHF23 and related proteins:
HDAC inhibitors
Histone methyltransferase inhibitors
PHD finger modulators
PHF23 expression as:
PHF23 interacts with:
| Partner | Interaction | Functional Role |
|---|---|---|
| HDAC1/2 | Direct binding | Repression complexes |
| LSD1 | Direct binding | Demethylation |
| REST | Co-repressor | Neuronal gene silencing |
| CoREST | Complex | Transcriptional repression |
| BRAF35 | Chromatin | Gene regulation |
| Pathway | PHF23 Role |
|---|---|
| Neuronal activity | Immediate-early gene regulation |
| Stress response | Gene activation/repression |
| Development | Cell fate determination |
| Apoptosis | Survival gene regulation |
PHF23 regulates: